The Pharma Data

MARCH 11, 2021

And at Pharmaceuticals, we are seeing success in our late-stage pipeline and are very well positioned with the investments we are making in our future. We plan to continue to grow at Pharmaceuticals despite patent expirations and only expect to register a modest decline in sales in 2024,” he said. through 2023.

Science 52

Science Pharmaceuticals Licensing Licensing 52

Drug Target Review

JULY 31, 2023

Michelle.Arkin@UCSF.edu Author Bio: Michelle Arkin Michelle Arkin is a chemical biologist, Professor and Chair of Pharmaceutical Chemistry, and Director of the Small Molecule Discovery Center (SMDC) at UCSF. She earned her PhD in chemistry at Caltech and held a Damon Runyon postdoctoral fellowship at Genentech.

DNA 98

DNA Small Molecule Science Cell Biology 98

The Pharma Data

OCTOBER 19, 2020

a multinational pharmaceutical company, where he was the head of Research & Development and responsible for the R&D strategy (France). in Cell Biology from Utrecht University. Dr. Kraan joins AM-Pharma from Pierre Fabre S.A., Before Pierre Fabre, Dr. Kraan was head of R&D at Stallergenes Greer Ltd. About AM-Pharma.

Trials 40

Trials Small Molecule Cell Biology Clinical Trials 40

Elrig

APRIL 29, 2024

With a background in Bioinformatics and Computational Biology, she has a keen interest in using technology to solve problems in healthcare and medicine. Harini joined Serna Bio in early 2021 and has been an integral part of the multidisciplinary teamworking on target ID platform development to drug discovery.

Bioinformatics 59

Bioinformatics Drugs Molecular Biology Cell Based Assays 59

New Drug Approvals

JANUARY 9, 2024

As such, it has been proposed that inhibiting CDK7 would provide a potent means of inhibiting cell cycle progression, which may be especially relevant given that there is compelling evidence from gene knockout studies in mice for lack of an absolute requirement for CDK2, CDK4 and CDK6 for the cell cycle at least in most cell types (M alumbres et al.,

Production 62

Production DNA RNA Regulations 62

Codon

APRIL 9, 2024

When Louis Miller, now Chief of Malaria Cell Biology at the NIH, attended a malaria conference in Shanghai in 2008, he asked: Who discovered artemisinin? Medical research groups were joined by pharmaceutical companies, chemical and spice factories, botany institutes, and insect science institutes. Nobody had an answer.

Drugs 137

Drugs Science Research Doctors 137

Drug Target Review

JANUARY 16, 2025

She has a PhD in Microbiology and Cell Biology from the University of Illinois, followed by work in biochemistry as a post-doctoral fellow at UCSF. Pharmaceuticals , 16(7):996, 2023. Ajay N Jain Ajay is VP of Research for the Optibrium s BioPharmics Division. References Lipinski CA, Lombardo F, Dominy BW, Feeney PJ.

Drug Development 52

Drug Development Small Molecule Drugs FDA Approval 52